29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
Last week, on November 7 at the American Bar Association’s annual labor and employment law conferen...
Read More >
Connecticut recently passed "An Act Establishing a Tax Credit for Employers That Make Payments on Ce...
Read More >
In proposed regulations released last week, the Department of Labor (DOL) finally put forward a revi...
Read More >
The Internal Revenue Service has announced the 2020 limits that affect the operation of tax-qualifie...
Read More >
Citing shortcomings in Federal anti-discrimination law, a growing number of state and local legislat...
Read More >
As we previously reported, Nevada has enacted a personal leave law, which, effective January 1, 2020...
Read More >